Skip to content

A Clinical Study to Assess the Effect of an Ayurvedic Medicine (Praval Panchamrita Rasa) in improving Low Calcium Levels in children aged 9 to 16 years.

A Prospective, Open-Label, Single-arm Study to Evaluate the Efficacy of Praval Panchamrita Rasa on Calcium Deficiency in Children aged 9 to 16 years - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100871
Enrollment
30
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E58- Dietary calcium deficiency

Interventions

None listed

Sponsors

National Institute of Ayurveda, Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 9-16 years of age of either sex. 2. Children with clinical sign and symptoms of calcium deficiency. 3. Children with Serum calcium level less than 8.6mg/dl .

Exclusion criteria

Exclusion criteria: 1. Children with Serum calcium level smaller than 5mg/dl or vitamin D (smaller than 12ng/ml) deficiency. 2. Children with major systemic illness requiring hospitalization. 3. Children with pre-diagnosed severe mal-absorption disorders such as celiac disease, crohn s disease and lactose intolerance, which can significantly impact calcium absorption. 4. Children with any congenital anomalies or birth defects or genetic disorder or malignancy. 5. Children with severe malnutrition, making it difficult to isolate calcium deficiency. 6. Children who are under recent or ongoing use of high dose calcium supplements. 7. Any subject taking hormone replacement therapy which might affect bone metabolism.

Design outcomes

Primary

MeasureTime frame
Changes in the level of serum calcium from baseline to 12 weeks.Timepoint: At the end of the study

Secondary

MeasureTime frame
1. Change in ionized calcium, inorganic phosphate, alkaline phosphatase level and bone mineral density (BMD). 2. Change in the clinical signs and symptoms Timepoint: At the end of the study

Countries

India

Contacts

Public ContactDr Aswathi K M

National Institute of Ayurved, Jaipur

dr.bdsharma@yahoo.co.in9887859095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026